Renal cancer: What can we expect from emerging new technologies: Radiofrequency and cryoablatic ?

Abstract

Radiofrequency and cryoablation are both minimally invasive techniques applied to the treatment of renal cell carcinoma. These techniques allow in situ destruction of neoplasm. Although cryotherapy is the most studied, radiofrequency is the most currently used technique. Indications mostly accepted as elective indication are the less than 4 cm in diameter exophytic tumors. Radiofrequency and cryoablation can also be proposed in patients with solitary kidney, multiple bilateral tumors and patients with contraindication for surgical resection.

The radiofrequency parietal tract can be coagulated at the time of radiofrequency electrode withdrawal reducing the rare risk of parietal tumor dissemination.

Preliminary oncological results in exophytic small renal tumors are promising with only few complications. A longer follow up is however mandatory to better define the place of these two new technologies in the treatment of renal cancer.